Summary of findings ‐ nebulised azithromycin vs azithromycin
FEV1 % predicted: absolute change from baseline · children with cystic fibrosis
1 finding from 1 review
- Macrolide antibiotics (including azithromycin) for cystic fibrosis 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 45 participantsVery low